Landauer, Inc. Appoints Greg Groenke To President Of IZI Medical Products
GLENWOOD, Ill., Oct. 4, 2012 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, today announced that it appointed Greg Groenke to President of Landauer's IZI Medical Products business effective immediately.
"Greg is an experienced healthcare professional with a proven track record of leadership and strong operating results," said Bill Saxelby , President and Chief Executive Officer of Landauer, Inc. "Greg's demonstrated proficiency in strategy and product development, along with his medical device regulatory and manufacturing experience within the surgical, orthopedic spine and interventional radiology segments, will enable him to make an immediate impact on our organization."
In this role, Mr. Groenke will set and lead the strategic and operating direction for the IZI Medical Products business. Prior to Landauer, Mr. Groenke served as Senior Vice President/General Manager of Environmental Technologies at Cardinal Health, where he was responsible for a $650 million global business. He has extensive experience in medical device product development and was responsible for business development earlier in his career with Cardinal Health. Prior to joining Cardinal Health, Greg worked for Johnson and Johnson's Ethicon Endo – Surgery business.
Mr. Groenke earned a Master in Business Administration from The University of Minnesota's Carlson School of Management and a Bachelor of Mechanical Engineering from The University of Minnesota.
"Landauer is a world leader in radiation science and services, and I am delighted to join such a dynamic, innovative company," said Mr. Groenke. "I believe there are extraordinary opportunities to grow and build shareholder value as we achieve our strategic growth initiatives. I look forward to working closely with the IZI employees, as well as our customers, shareholders and business partners."
The Company is also very pleased to announce that Helen Shafer , the founder of the IZI business, will continue to work with Greg in a new capacity as Senior Vice President of Strategic Initiatives. "I am very excited about the opportunity to work with Greg and the Landauer team to help realize the full potential of the IZI business that I have grown over the last 15 years. Greg's arrival will give me an opportunity to balance my personal and professional responsibilities, and I am committed to working with Greg to expand the IZI platform."
"The combination of Helen's experience, knowledge of the industry, and her approach to business development coupled with Greg's product development and marketing capabilities will drive continued product development and market expansion for our Medical Products business segment. IZI Medical Products will be an integral part of Landauer's growth strategy going forward," said Saxelby.
Landauer is a leading global provider of technical and analytical services to determine occupational and environmental radiation exposure and is the leading domestic provider of outsourced medical physics services. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings. The Company provides its dosimetry services to approximately 1.7 million individuals globally. In addition, through its Global Physics Solutions subsidiary, the Company provides therapeutic and imaging physics services to the medical physics community. Through its IZI Medical Products subsidiary, the Company provides medical consumable accessories used in radiology, radiation therapy, and image guided surgery procedures.
SOURCE Landauer, Inc.
More by this Source
Landauer, Inc. Declares Regular Cash Dividend
May 20, 2013, 16:00 ET
Landauer, Inc. Reports Fiscal 2013 Second Quarter Results
May 06, 2013, 16:00 ET
Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Second Quarter 2013 Results
Apr 23, 2013, 18:20 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.